Edition:
United States

Lydall Inc (LDL.N)

LDL.N on New York Stock Exchange

51.13USD
30 Sep 2016
Change (% chg)

$0.04 (+0.08%)
Prev Close
$51.09
Open
$50.91
Day's High
$51.65
Day's Low
$50.91
Volume
54,285
Avg. Vol
29,597
52-wk High
$53.00
52-wk Low
$25.41

Latest Key Developments (Source: Significant Developments)

Lydall announces financial results for the Q2 ended June 30, 2016
Tuesday, 2 Aug 2016 04:30pm EDT 

Lydall Inc : Q2 earnings per share $0.63 . Q2 adjusted earnings per share $0.70 . Lydall announces financial results for the second quarter ended June 30, 2016 . Q2 sales rose 2 percent to $137.2 million ."looking to balance of Q3, orders in our automotive segments remain strong".  Full Article

Lydall acquires Texel for about $96 mln
Friday, 8 Jul 2016 06:00am EDT 

Lydall Inc : Lydall acquires Texel, a leader in innovative technical materials . Lydall Inc says deal valued at approximately $96 million . Acquisition is expected to be accretive to cash flow from operating activities within 12 months . About $1 million of additional non-recurring transaction and integration expenses related to acquisition will be incurred over second half 2016 . Expects to generate estimated annual cost savings of approximately $2 million . Acquisition is expected to be accretive to Lydall's earnings, net of effect of purchase accounting . Lydall's financial results for Q2 2016 will include less than $2 million of expenses related to strategic initiatives .Acquisition was financed through a combination of cash on hand and $85 million of borrowings.  Full Article

Lydall announces CFO departure
Monday, 13 Apr 2015 04:09pm EDT 

Lydall:Says Robert K. Julian, Executive Vice President and Chief Financial Officer, has resigned his position with the Company to pursue another career opportunity.Julian plans to continue as Chief Financial Officer of Company through May 1 to facilitate an orderly transition of his responsibilities.Company intends to initiate a search process for the Chief Financial Officer position.  Full Article

Lydall announces divestiture of Charter Medical to Fenner PLC's subsidiary
Friday, 30 Jan 2015 12:41pm EST 

LYDALL, INC:Completes sale of Charter Medical, Ltd., a designer and manufacturer of specialty single-use products utilized in blood management, blood filtration and biopharmaceutical applications for the collection, processing, and storage of biological fluids.Charter Medical was acquired by a subsidiary of Fenner PLC for a purchase price of $29.9 million.  Full Article

BRIEF-Lydall announces financial results for the Q2 ended June 30, 2016

* Lydall announces financial results for the second quarter ended June 30, 2016